Skip to content
10-Q

Quarterly Report

Vilacto Bio Inc.

0001663577-18-000385

← back to feed
Filed
Aug 20, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Jul 31, 2018 90M sh
Cash And Equivalents Q1 2019 · Jun 30, 2018 $48.74K
Cash And Equivalents Q1 2019 · Mar 31, 2017 $22.02K
Stockholders Equity Q1 2019 · Jun 30, 2018 −$883.4K
Current Liabilities Q1 2019 · Jun 30, 2018 $1.08M
Current Liabilities Q1 2019 · Mar 31, 2018 $1.25M
Total Liabilities Q1 2019 · Jun 30, 2018 $1.08M
Total Liabilities Q1 2019 · Mar 31, 2018 $1.25M
Current Assets Q1 2019 · Jun 30, 2018 $192.45K
Current Assets Q1 2019 · Mar 31, 2018 $308.87K
Total Assets Q1 2019 · Jun 30, 2018 $198.15K
Total Assets Q1 2019 · Mar 31, 2018 $309.77K
Net Income Q1 2019 · Mar 31, 2018 $951.4K
Net Income Q1 2019 · Jun 30, 2017 −$73.03K
Operating Cash Flow Q1 2019 · Jun 30, 2017 −$77.01K
Sga Expense Q1 2019 · Jun 30, 2017 $19.02K
Operating Income Q1 2019 · Jun 30, 2017 −$71.8K